LYAR
Basic information
Region (hg38): 4:4267701-4290154
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LYAR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 23 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 0 | 0 |
Variants in LYAR
This is a list of pathogenic ClinVar variants found in the LYAR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-4267926-A-C | not specified | Uncertain significance (Jun 02, 2023) | ||
4-4267932-G-C | not specified | Uncertain significance (Sep 26, 2023) | ||
4-4267938-T-C | not specified | Uncertain significance (Aug 08, 2023) | ||
4-4273595-C-G | not specified | Uncertain significance (Jun 28, 2022) | ||
4-4273601-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
4-4274372-G-A | not specified | Uncertain significance (Feb 03, 2022) | ||
4-4274442-T-G | not specified | Uncertain significance (Jan 04, 2024) | ||
4-4274474-T-A | not specified | Uncertain significance (May 17, 2023) | ||
4-4274580-T-G | not specified | Uncertain significance (May 13, 2024) | ||
4-4274590-C-A | not specified | Uncertain significance (Aug 13, 2021) | ||
4-4274636-T-A | not specified | Uncertain significance (Jul 05, 2023) | ||
4-4274649-C-A | not specified | Uncertain significance (Dec 21, 2023) | ||
4-4274742-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
4-4274763-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
4-4279481-T-C | not specified | Uncertain significance (Sep 23, 2023) | ||
4-4279491-T-A | not specified | Uncertain significance (Jun 22, 2024) | ||
4-4279506-C-G | not specified | Uncertain significance (Feb 16, 2023) | ||
4-4279669-G-T | not specified | Uncertain significance (Nov 21, 2023) | ||
4-4279690-C-G | not specified | Uncertain significance (Jan 05, 2022) | ||
4-4279722-T-A | not specified | Uncertain significance (Apr 04, 2023) | ||
4-4281812-C-G | not specified | Uncertain significance (May 27, 2022) | ||
4-4281813-T-A | not specified | Uncertain significance (Mar 21, 2023) | ||
4-4281847-T-A | not specified | Uncertain significance (May 23, 2023) | ||
4-4281886-T-C | not specified | Uncertain significance (May 29, 2024) | ||
4-4283681-T-C | not specified | Uncertain significance (Jul 20, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LYAR | protein_coding | protein_coding | ENST00000343470 | 8 | 22469 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.76e-7 | 0.815 | 125713 | 0 | 34 | 125747 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.218 | 211 | 202 | 1.04 | 0.0000106 | 2536 |
Missense in Polyphen | 42 | 41.065 | 1.0228 | 576 | ||
Synonymous | -1.33 | 89 | 74.4 | 1.20 | 0.00000440 | 631 |
Loss of Function | 1.43 | 13 | 19.9 | 0.654 | 9.34e-7 | 260 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000184 | 0.000184 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000927 | 0.0000924 |
European (Non-Finnish) | 0.000212 | 0.000211 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000493 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in the maintenance of the appropriate processing of 47S/45S pre-rRNA to 32S/30S pre-rRNAs and their subsequent processing to produce 18S and 28S rRNAs (PubMed:24495227). Also acts at the level of transcription regulation. Along with PRMT5, binds the gamma-globin (HBG1/HBG2) promoter and represses its expression (PubMed:25092918). In neuroblastoma cells, may also repress the expression of oxidative stress genes, including CHAC1, HMOX1, SLC7A11, ULBP1 and SNORD41 that encodes a small nucleolar RNA (PubMed:28686580). Preferentially binds to a DNA motif containing 5'-GGTTAT-3' (PubMed:25092918). Stimulates phagocytosis of photoreceptor outer segments by retinal pigment epithelial cells (By similarity). Prevents nucleolin/NCL self-cleavage, maintaining a normal steady- state level of NCL protein in undifferentiated embryonic stem cells (ESCs), which in turn is essential for ESC self-renewal (By similarity). {ECO:0000250|UniProtKB:Q08288, ECO:0000269|PubMed:24495227, ECO:0000269|PubMed:25092918, ECO:0000269|PubMed:28686580}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- rvis_EVS
- 0.33
- rvis_percentile_EVS
- 73.54
Haploinsufficiency Scores
- pHI
- 0.706
- hipred
- Y
- hipred_score
- 0.658
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.393
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lyar
- Phenotype
- embryo phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;rRNA processing;erythrocyte development;positive regulation of phagocytosis
- Cellular component
- photoreceptor outer segment;nucleus;nucleolus;cytoplasm
- Molecular function
- DNA binding;RNA binding;protein binding;metal ion binding